FDA unveils drugs to receive expedited review in support of 'national priorities'

The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at ...
Nasdaq

The European Medicines Agency (EMA) Has Approved an Additional Subcutaneous Administration Option for TAKHZYRO® (lanadelumab) for Patients Aged 12 Years and Above with ...

ZURICH, Feb. 24, 2025 /PRNewswire/ -- Takeda (TSE: 4502) (NYSE: TAK) announced today that the EMA has approved an additional 2 mL pre-filled pen option for TAKHZYRO® (lanadelumab) for subcutaneous ...
The White House

ONDCP Releases Trump Administration’s Statement of Drug Policy Priorities

Today, the White House Office of National Drug Control Policy (ONDCP) is announcing the release of the Trump Administration’s Drug Policy Priorities, a comprehensive and coordinated blueprint to ...
STAT

Head of addiction medicine society warns of treatment cuts and rising threat of gambling

Trump administration's stance on involuntary commitment for people with addiction isn't supported by evidence, an addiction ...
Wane

FDA says decongestant in many cold medicines doesn’t work. So what does?

WASHINGTON (AP) — Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading decongestant found in hundreds of over-the-counter medicines ...

Trump says cost of IVF drugs will decrease "dramatically" thanks to price negotiations

President Trump says his administration will "dramatically slash the cost of IVF" by negotiating lower drug prices, though ...